RHONDA FOUNTAIN: Open Payments
NPI 1013228360 · BROWNSTOWN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 19 payments from 9 companies in 2025. Trend: 2023 $523 · 2024 $298 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $94 |
| Lilly USA, LLC | 5 | $80 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Abbott Laboratories | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $3 |
Products named: MOUNJARO, Rybelsus, Ozempic, JARDIANCE, Wegovy, INSPIRE, BEVESPI AEROSPHERE, FARXIGA.
Industry payments across IN — which companies pay providers there.
